Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
glucose analog
radiopharmaceutical |
| gptkbp:abbreviation |
gptkb:FDG
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:CASNumber |
63592-64-7
|
| gptkbp:chemicalFormula |
C6H11FO5
|
| gptkbp:discoveredIn |
1976
|
| gptkbp:hasIsland |
gptkb:fluorine-18
|
| https://www.w3.org/2000/01/rdf-schema#label |
fluorodeoxyglucose (FDG)
|
| gptkbp:IUPACName |
gptkb:2-deoxy-2-[18F]fluoro-D-glucose
|
| gptkbp:metabolism |
cells with high glucose uptake
|
| gptkbp:molecularWeight |
181.15 g/mol
|
| gptkbp:parent |
glucose
|
| gptkbp:photographed |
gptkb:PET_scanner
|
| gptkbp:producedBy |
Centrifuge
|
| gptkbp:radioactiveHalfLife |
109.8 minutes
|
| gptkbp:sideEffect |
radiation exposure
|
| gptkbp:usedFor |
cancer diagnosis
cardiology imaging neurology imaging |
| gptkbp:usedIn |
gptkb:positron_emission_tomography
|
| gptkbp:bfsParent |
gptkb:positron_emission_tomography_(PET)
|
| gptkbp:bfsLayer |
5
|